Mycosis fungoides (MF), the most common type of cutaneous T鄄 cell lymphoma, has various unspecific clinical and histological characteristics. Its early diagnosis is challenging. The application of T鄄 cell receptor (TCR) gene clonal rearrangement to the diagnosis of MF has been widely studied. In this study, we used 
Mycosis fungoides (MF) is the most common type of primary cutaneous Tcell lymphoma. Most patients have an infiltration of small to medium size mature helper CD4 T cells with cerebriform nuclei; a few patients have an infiltration of cytotoxic CD8 T cells. MF often starts as an unspecific erythema (patch phase) similar to many inflammatory skin diseases. Progression from patch phase to plaque and tumor phase often takes many years. The diagnosis of MF depends on a combination of clinical and pathologic examination. However, early MF (patch phase) pathology is unspecific and may simulate a variety of benign inflammatory skin diseases, such as chronic eczema, neurodermatitis, and lichen planus. Due to a lack of specific clinicopathologic presentation, the early diagnosis of MF is a great challenge.
During the differentiation of stem cells to T cells, nontranscriptional gene fragments are rearranged into a complete gene in a process catalyzed by DNA recombinase. The new gene gains transcriptional activity, expressing antigenspecific receptor as T cells continue differentiating. In contrast, if gene rearrangement fails, cells undergo apoptosis. This process is termed Tcell receptor (TCR) gene rearrangement. Polyclonal rearrangement happens during normal Tcell development. However, all hematopoietic and lymphoid tumor cells share the same TCR gene rearrangement, namely monoclonal rearrangement. Accordingly, by using Southern blot and polymerase chain reaction (PCR) , researchers analyze clonality by detecting TCR gene rearrangement of T cells in skin lesions. Previous gene rearrangement studies have relied heavily on Southern blot analysis. However, PCR has several advantages (simple technique, short cycle, no radioactive contamination, compatible with paraffinembedded tissue samples, and high detection rate) and has been widely used in clinical and experimental detection to replace Southern blot analysis.
As T cells (including 琢 /茁 and 酌 /啄 T cells) completely keep the rearranged TCR酌 gene with relatively simple structure, designing PCR primers to obtain a high detection rate is easy. Therefore, most investigators choose TCR酌 as a target gene for lymphoma clonal gene rearrangement [1] . As a part of the European BIOMED2 program, the emergence of specific primers for TCR茁 gene has greatly enhanced the detection rate of clonal TCR茁 gene rearrangement [2, 3] . In recent years, investigators have gradually applied PCR to analyze TCR gene rearrangement in cutaneous lymphoma [48] , primarily detecting the rearrangement of TCR茁 and TCR酌 . Because of the complexity and diversity of TCR gene rearrangement and differences in primer design and numbers, samples and PCR products, results of these studies have discrepancies, showing 50% to 90% of Tcell lymphomas had TCR酌 gene rearrangement. When narrowed down to the MF stages, the detection rates were 52% to 75% for patch phase, 73% to 83% for plaque phase, and 90% to 100% for the tumor [48] . In this study, we detected TCR茁 and TCR酌 gene rearrangement in paraffinembedded tissue samples from patients with early suspected MF to further explore the application of TCR gene rearrangement to early diagnosis of MF.
Materials and Methods

Patients and samples
The specimens were from 19 patients with suspected early MF, 6 patients with typical MF (2 plaque phase and 4 at tumor phase as positive control), and 6 patients with chronic inflammatory skin disease (3 lichen planus, 2 psoriasis, and 1 neurodermatitis as negative control) examined in the Pathology Division at the Department of Dermatology and the Department of Pathology in the West China Hospital of Sichuan University between 2001 and 2007. Histological diagnosis of MF was confirmed by a senior cutaneous pathologist and a lymphatic hematopoietic pathologist according to Lever爷s diagnostic criteria [9] and the 2005 WHOEORTC classification of cutaneous lymphoma [10] . Early suspected patients were 9 men and 10 women, aged 15 to 79 years with a mean age of 53 and median age of 59. All 19 patients had multiple skin lesions in the upper limbs (16 cases), trunk (15 cases), and lower limbs (14 cases). Some patients had skin lesions in the face, neck, and head. The lesions mainly characterized as multiple erythema and papule covered with small scales. A few patients had pigment changes, skin atrophy, and ichthyosislike skin lesions. Most patients had varying degrees of itching and 1 had a burning sensation/itch. , and the BIOMED2TCR酌 multiplex PCR amplification system [13] ), two TCRβ gene rearrangement primer sets (D 1 J 2 [14] and the BIOMED2TCR茁 multiplex PCR amplification system [13] ), and the PCR targets are listed in Tables 1 and 2 . PCR was conducted in a 25 滋 L reaction volume containing 0.2 mmol/L dNTP, 1.5 mmol/L MgCl2, 1 滋 mol/L primers, 1.25 U Taq enzyme (Takara Bio Inc.), and 0.5 to 1 滋 g template DNA.
Histological examination and immunophenotyping
Amplifications with primer T VG /T JX were done with touchdown PCR. The amplifying conditions for V 25 /V 812 /JGT1 were as follows: denaturation at 95益 for 3 min, 30 cycles of 94益 for 30 s, 60益 for 45 s, and 72益 for 45 s, followed by an extension at 72益 for 10 min; the amplifying condition for BIOMED2TCR酌 /茁 and D 1 J 2 were as follows: denaturation at 95益 for 3 min, 35 cycles of 95益 for 30 s, 60益 for 40 s, and 72益 for 1 min, followed by an extension at 72益 for 10 min. The PTC200 thermal cycler from MJ Research Inc. was used for all PCR reactions. 茁 globin was amplified as an internal control. A DNA sample from Jurkat cells, a Tcell lymphoma line, was used as a positive control. PCR products were electrophoresed on an 8% polyacrylamide gel and analyzed after silver staining. For heteroduplex analysis of gene rearrangement, 10 to 20 滋 L of PCR product from BIOMED2 system was denatured at 95益 for 5 min and then annealed at 4益 for 60 min. The resulting PCR products were electrophoresed on a 10% polyacrylamide gel and analyzed after silver staining.
DNA sequencing
The PCR product of a case of TCR gene rearrangement was randomly selected for DNA sequencing. The PCR product was purified with DNA Gel Extraction Kit (Axygen Biosciences Inc), cloned into a Tvector (PMD 20T Vector, Takara Bio Inc.) and sequenced with an ABI 377 DNA sequencer. The sequencing result was analyzed by the BLASTing gene database in NCBI for gene rearrangement.
Statistical methods
Statistical analysis was done with SPSS13.0 software. The Fisher exact test was applied and the difference was statistically significant when < 0.05.
Results
Morphology and immunophenotype
Nineteen patients with suspected early MF predominantly had lesions within the epidermis and shallow middle dermis. Eleven patients had epidermal hyperkeratosis and/or parakeratosis, acanthosis, and epidermal protuberance extension, including 5 had edema in the spinous layer and 3 had focal basal liquefaction degeneration. Fifteen had epidermotrophism of lymphoid cells, including 4 had linear arrangement of lymphoid cells in the basal layer ( Figure 1A ). Epidermal infiltrated cells had distorted or cerebriform nuclei and perinuclear halo which were deeply stained. All patients had lymphoid cell infiltration in superficial middle dermis: 9 had perivascular infiltration; 2 had striated infiltration in superficial dermal; 8 had scattered infiltration in the dermis. Dermal infiltrating cells were of small to medium size and individually were relatively large. In 2 cases, dermal infiltrating cells were smaller, had less cytoplasm and were stained deeper than those in the epidermis; some cells had distorted and heterogeneous nuclei ( Figure 1B) . Three cases had papillary dermal fibrosis. All suspected cases expressed two or more T cell markers (CD2, CD3着 , CD7, and CD45RO ) ( 
PCR amplification and DNA sequence
PCR results are shown in Table 3 . Of the 19 patients with suspected early MF, 13 (68.4% ) had TCR酌 gene 
Discussion
Early MF has a variety of clinical manifestations and unspecific pathologic characteristics. Typical characteristics include focal perivascular dermal infiltration of small to mediumsized lymphoid cells with cerebriform nuclei, or arrangement along the junction of the epidermis and dermis and edema in the spinous layer. Pautrier microabscesses and epidermotrophism, which have important diagnostic value, are not obvious or are missing in early MF [15] . MF may simulate chronic eczema, neurodermatitis, or other inflammatory skin diseases and requires longterm followup and repeated biopsy. As an important diagnostic method for MF, immunohistochemistry can determine the origin of tumor cells but can not determine the clonality of proliferating cells. Moreover, as early MF is often accompanied by reactive lymphocytes, many cases do not show a characteristic immunophenotype. For these cases, immunohistochemistry has a limited diagnostic value. Thus, molecular diagnosis is needed.
Analysis of clonal gene rearrangement plays an important role in the diagnosis of lymphoproliferative disease. Combining this approach with pathologic and immunohistochemical examinations may aid in the diagnosis of difficult cases. Currently, detecting TCR酌 gene rearrangement by PCR has become an important adjunct to the diagnosis of cutaneous Tcell lymphoma [16] . In this study, TCR gene rearrangement was detected in all typical MF cases but not detected in all chronic inflammatory skin disease cases, indicating that detecting TCR rearrangement by PCR is an effective adjunct to MF diagnosis.
In addition, when PCR was used to analyze gene rearrangement in tissues of atypical cutaneous T lymphocyte proliferative diseases, the sensitivity was 83.5% and specificity was 97.7% [8] . The positive rate of TCR酌 gene rearrangement in early MF suspected cases was reported to be 40% to 71% [6, 7] , which is useful for early diagnosis. Stevens . [17] conducted logistic regression analysis on some clinical and laboratory data and established a simple clinical scoring system to facilitate MF diagnosis. They found that the histological diagnosis of MF and TCR gene rearrangement are closely related (odds ratio = 14.4) and proposed a scoring program: TCR gene rearrangement positive scores 2.5, classical morphology scores 2.0, and classic clinical manifestation scores 1. 5 ; a total score equal to or greater than 3.5 indicates a high probability of MF (> 85% ). In our study, the clinical manifestations, histopathologic and immunologic phenotypes suggest all suspected cases were of possible MF. TCR酌 gene rearrangement was detected in 13 patients ( 68 . 4 % ) . Thus, we believe that these 13 cases can be diagnosed as early MF (patch phase). Four of the 13 patients were followed up and diagnosed with MF according to disease development and treatment response. The diagnosis of 6 patients was still unclear and further observation and followup was needed.
This study showed that the detection rate of clonal TCR酌 gene rearrangement was higher than that of TCR茁 . No clonal TCR茁 gene rearrangement was detected in the suspected cases. Currently, universal PCR primers can be designed at the V and J regions of 琢 , 茁 , 啄 and 酌 chains. However, all T cells (including 琢 /茁 and 酌 /啄 T cells) keep the rearranged TCR酌 gene. TCR酌 gene structure is relatively simple and has no variable D region, which facilitates primer design and PCR amplification. For this reason, researchers usually choose TCR酌 when analyzing TCR clonality. Therefore, TCR酌 gene is still a good target for the detection of clonal gene rearrangement in early MF.
In addition, no TCR茁 gene rearrangement was detected in the suspected cases. But false negative could not be ruled out because the PCR may have been affected by pretreatment of the archived paraffinembedded tissue samples. Although amplification of control 茁 globin (110 bp) was good, some target genes of greater or lesser size than 茁 globin (such as 250 to 300 bp or 80 to 100 bp fragments) may have been destroyed. In this study, we used primers to amplify 80 to 285 bp long fragments, so damaged DNA fragments could not be amplified in our PCR reaction, possibly causing false negative results.
False results are also inevitable in the interpretation of PCR results. Through optimizing PCR primer design and selecting a higher resolution technique, one can reduce false results. In this study, we used the higher resolution techniques of polyacrylamide gel electrophoresis and silver staining to display rearrangement bands and used heteroduplex analysis to verify gene rearrangement, both of which could reduce false positive results. In addition, the sensitivity of PCR has a certain range and false negatives can arise when the ratio of DNA from monoclonal proliferating lymphocytes to tha t from reactive lymphocytes is less than 1 % . If the amount of template DNA is too small , DNA from a single or several lymphocytes is highly amplified, similar bands like a monoclonal rearrangement may arise, namely pseudoclonality. Therefore, for paraffinembedded tissue samples, the initial amount of template DNA should be no less than 50 ng, of which DNA from reactive lymphocytes must be more than 5 ng 18] . Under the premise of not affecting PCR, an appropriate increase of the amount of template DNA can reduce pseudoclonality. In this study, template DNA was within a 200 to 500 ng range and the proportion of tumor cells was higher than 1%, thereby reducing false positive results.
Based on this study, we believe that, when MF is suspected and diagnosis cannot be made on clinical manifestations, regular histopathologic examination, and immunohistochemistry, TCR gene rearrangement is a valuable diagnostic adjunct. The detection of clonal TCR酌 gene rearrangement is recommended and the analysis of TCR茁 rearrangement can be performedalong with TCR酌 rearrangement for a few difficult cases.
However, it must be noted that gene rearrangement of antigen receptor is not involved in the malignant transformation of lymphocytes. These two processes occur independently. In general, gene rearrangement occurs before tumor transformation. On one side, clonally proliferating tumor cells harbor the same antigen gene rearrangement (monoclonality), whereas each T or B cell from benign lesions carries a unique type of gene rearrangement (polyclonality). Therefore, in theory, the genetic rearrangement analysis of antigen receptor gene is helpful to distinguish proliferating lymphoma and reactive lesions. On the other side, due to the independence of each other, the occurrence of clonal gene rearrangement does not indicate a malignant lesions, because some benign or reactive inflammatory lesions may also have clonal rearrangement. For example, clonal gene rearrangements could be detected in benign monoclonal 酌 globulin disease, acute smallpoxlike mosslike rash, other skin inflammatory diseases, and immune deficiency disease with severe EpsteinBarr virus infection [19] . Conversely, the lack of monoclonal gene rearrangement is not equivalent to benign lesions. In many conditions, such as the low coverage of primers, the absence of a tested gene rearrangement in the tumor genome, DNA degradation in the sample, and the number of tumor cells below the detection sensitivity threshold, clonal gene rearrangement may not be detected. Therefore, the early diagnosis of MF must be based on pathologic changes, with immunohistochemistry and gene rearrangement analysis as important adjunct diagnostic tools. For some suspected cases with no clonal gene rearrangement, longterm followup and multiple pathologic examinations should be done to confirm the diagnosis [20] .
